ClinicalTrials.gg
Not yet recruitingNCT07895758SPAQ-ADOUpdated Oct 26, 2026

Assessment of the Seasonality of Depressive Symptoms in Adolescents

An observational study in Depressive Symptoms, sponsored by University Hospital, Rouen. Not yet recruiting at 1 site in France. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University Hospital, Rouen · Observational

Updated Oct 26, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
210
Ages
11 Years to 17 Years
Sex
All
01

Study summary

The seasonality of affective disorders-particularly depressive symptoms-is well-documented in adults, yet it remains under-researched in adolescents. Recent studies, however, suggest that young people aged 11 to 20 experience marked seasonal fluctuations in mood. In both hospital pediatric settings and the ECLIPSE program, many adolescents are admitted due to depressive symptoms or suicidal crises; however, the role of seasonality in these cases remains largely unexplored. ECLIPSE (a Child and Adolescent Psychiatry Liaison and Emergency Consultation Team) is a service at the Rouen University Hospital dedicated to providing emergency and post-emergency care for children and adolescents experiencing psychological distress. It is designed for minors aged 3 to 16 whose psychological state requires prompt intervention, but not hospitalization. Clinical observation suggests that, for some patients, depressive manifestations follow an annual cycle. Identifying such seasonal patterns could help improve our understanding of vulnerability factors and enable the adaptation of prevention and care strategies. The Seasonal Pattern Assessment Questionnaire (SPAQ) (Reynaud et al., 2022)-used in adults (>18 years old) to screen for seasonal affective disorder via a Global Seasonality Score (GSS)-is a simple, self-administered tool that can easily be used with adolescents. Its application in this context would allow for the assessment of the seasonality of depressive symptoms within this hospitalized population.

Read the detailed description

The hypothesis of this project is that, among adolescents hospitalized in pediatric wards for depressive symptoms, there exists a measurable seasonality of mood-characterized by significant variations in symptoms throughout the year-which can be identified using the Seasonal Pattern Assessment Questionnaire (SPAQ).

02

Conditions studied

  • Depressive Symptoms

Keywords

  • teenagers
  • mental health
  • SPAQ questionnaire
03

In context

Depression

8,245 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 210 is above the median of 158 across 1,111 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University Hospital, Rouen is the lead sponsor of 417 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Participants will be recruited from the Rouen University Hospital, within pediatric departments that admit adolescents receiving care for mental health reasons.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 11-17 years.
  • Hospitalization in a pediatric ward (or post-emergency pediatric psychiatric care within the ECLIPSE unit) for depressive symptoms/suicidal crisis linked to a depressive state (DSM-5 criteria).
  • Proficiency in French and the ability to self-complete the SPAQ questionnaire following clinical stabilization.
  • Provision of information to the minor and no objection from those holding parental authority (in accordance with local procedures).
  • First inclusion only (in the event of readmission, the initial episode is the one considered).

Exclusion criteria

Exclusion Criteria:

  • Conditions that interfere with the completion of a reliable self-report questionnaire: moderate-to-severe intellectual disability, autism spectrum disorder (ASD) with significant communication impairments, an acute mental state (severe psychotic disorganization, acute intoxication/withdrawal, delirium), or severe physical pain.
  • Absence of a current depressive state.
  • Manic/hypomanic episode predominant at the time of data collection (depressive symptoms take priority for the purpose of assessing seasonality).
  • Insufficient command of the French language or sensory impairments that prevent the assessment from being administered, even with assistance.
  • SPAQ not completed (or major missing data, rendering the GSS uninterpretable).
  • Patient refusal.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
210 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • Diagnostic testMeasuring the intensity of the seasonality of depressive symptoms in adolescents

    Adolescents who agree to participate will be invited to complete the SPAQ questionnaire either independently or with the assistance of a team member. It will be administered on a single occasion and is expected to take approximately 10 to 15 minutes to complete.

06

What researchers measure

Primary outcomes

  1. To assess the intensity of the seasonality of depressive symptoms in adolescents receiving care for child psychiatric reasons at the Rouen University Hospital

    The intensity of the seasonality of depressive symptoms will be measured using the continuous Global Seasonality Score (GSS) from the SPAQ. The GSS is the sum of six items related to seasonal variation (sleep, social activity, mood, weight, appetite, and energy), each rated from 0 to 4, resulting in a total score ranging from 0 to 24. A high score indicates greater reported seasonal variations

    Time frame: 1 day

Secondary outcomes

  1. Determine the proportion of adolescents with a profile consistent with seasonal affective disorder, based on the Global Seasonality Score (GSS) from the SPAQ.

    Proportion of adolescents whose responses to the SPAQ questionnaire correspond to a profile consistent with seasonal affective disorder (SAD) or a subsyndromal profile (S-SAD). The classification is based on two complementary elements: * The GSS: the seasonality score, ranging from 0 to 24. * Perceived impairment: the extent to which seasonal variations affect the adolescent's life, assessed via a specific item in the questionnaire. The classification will be based on the following profiles : 1. Profile consistent with SAD (Seasonal Affective Disorder) \- GSS ≥ 11 and at least moderate impairment. The adolescent reports significant seasonal variations, accompanied by at least a moderate impact. 2. Profile compatible with S-SAD (Subsyndromal Seasonal Affective Disorder) Two scenarios are possible: * A GSS (Global Seasonality Score) between 8 and 10, accompanied by at least mild impairment. * A GSS ≥ 11, but without significant impairment. Seasonal variations are present, but their

    Time frame: 1 day

  2. Describe the clinical and sociodemographic characteristics associated with seasonal variation in depressive symptoms (age, sex, psychiatric history, context of hospitalization, family psychiatric history (especially disorders)).

    Determination of factors associated with seasonality (age, sex, medical history, reason for hospitalization, and family and personal psychiatric history).

    Time frame: 1 day

  3. Describe the clinical and sociodemographic characteristics associated with seasonal variation in depressive symptoms (age).

    Determination of factors associated with seasonality (age)

    Time frame: 1 day

  4. Describe the clinical and sociodemographic characteristics associated with seasonal variation in depressive symptoms (sex).

    Determination of factors associated with seasonality (sex).

    Time frame: 1 day

  5. Describe the clinical and sociodemographic characteristics associated with seasonal variation in depressive symptoms (psychiatric history).

    Determination of factors associated with seasonality (psychiatric history).

    Time frame: 1 day

  6. Describe the clinical and sociodemographic characteristics associated with seasonal variation in depressive symptoms (context of hospitalization).

    Determination of factors associated with seasonality (reason for hospitalization).

    Time frame: 1 day

  7. Describe the clinical and sociodemographic characteristics associated with seasonal variation in depressive symptoms (medical history).

    Determination of factors associated with seasonality (medical history).

    Time frame: 1 day

  8. To evaluate the feasibility of using the SPAQ in an adolescent population hospitalized in a pediatric setting.

    The completion rate for the SPAQ questionnaire is an important indicator of the feasibility of its use among adolescents hospitalized in pediatric settings. It makes it possible to measure the proportion of questionnaires that are filled out-ideally, with a sufficient level of completeness to be usable. The completion rate for the SPAQ questionnaire is number of completed questionnaires out of the number of questionnaires for which administration was undertaken. The feasibility of using the SPAQ will be assessed, in particular, by the questionnaire completion rate, defined as the proportion of fully completed and usable questionnaires out of the total number of questionnaires that were initiated.

    Time frame: 1 day

  9. To evaluate the relevance of using the SPAQ in an adolescent population hospitalized in a pediatric setting (Taken Time).

    The time taken to complete the questionnaire will make it possible to assess its ease of use. The administration time is determined by subtracting the start time from the end time to obtain the duration, in minutes, taken to complete the questionnaire.

    Time frame: 1 day

  10. To evaluate the relevance of using the SPAQ in an adolescent population hospitalized in a pediatric setting (Feedback from adolescents).

    The aim is to assess the understanding of the questions, the difficulties encountered, and the feelings experienced in relation to the questionnaire. The acceptability of the questionnaire will be assessed by collecting brief feedback from the adolescents after they have completed it. This will focus, in particular, on their understanding of the questions, the ease of filling out the questionnaire, its perceived length, and any difficulties encountered. The responses will be analyzed descriptively, using counts and proportions for the closed-ended questions.

    Time frame: 1 day

  11. Comparing the SPAQ score with the clinical assessment of seasonality

    This assessment is part of the standard child and adolescent psychiatric evaluation and requires no additional procedures; the clinician will conduct it without knowledge of the SPAQ score. The adolescent completes the questionnaire. The investigator calculates their GSS score, which measures the magnitude of the reported seasonal variations. A child and adolescent psychiatrist explores the seasonal nature of depressive episodes using a semi-structured interview based on DSM-5 criteria. Researchers compare the SPAQ result with the conclusion of the clinical assessment to examine the level of agreement between the two. The DSM-5 is a reference manual used by mental health professionals to describe, classify, and diagnose psychiatric disorders according to defined criteria. The DSM-5 serves as a reference for exploring the seasonal nature of depressive episodes.

    Time frame: 1 day

07

Study locations

1 site
  • University Rouen Hospital
    Rouen, 76031, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07895758
Responsible party
Sponsor
First posted
Oct 26, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Jan 2, 2028 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Oct 26, 2026

Study contacts

Nabila NL LAAJAIL, Director
Contact
nabila.laajail@chu-rouen.fr
02 32 88 82 65 ext. +33
vincent VF FERRANTI, 02 32 88 82 65
Contact
vincent.ferranti@chu-rouen.fr
02 32 88 82 65 ext. +33
Héloise HY YOUNG, Professor
study director · Univerity Rouen Hospital
Axel AH HUET, medical resident
principal investigator · university Rouen Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion